Clinical trials
Multiple Sclerosis trials in Turkey (Türkiye) with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 11 |
| 2021 | 20 |
| 2022 | 17 |
| 2023 | 26 |
| 2024 | 17 |
| 2025 | 19 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Unknown status | 29 |
| Recruiting | 12 |
| Not yet recruiting | 9 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gazi University | 12 |
| Dokuz Eylul University | 11 |
| Hacettepe University | 11 |
| Istanbul University - Cerrahpasa | 8 |
| Firat University | 6 |
| Ondokuz Mayıs University | 5 |
| Ankara Yildirim Beyazıt University | 4 |
| Ege University | 4 |
| Marmara University | 4 |
| Abant Izzet Baysal University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 149 |
| Fatigue | 24 |
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Pain | 7 |
| Sleep Initiation and Maintenance Disorders | 5 |
| Urinary Incontinence | 5 |
| Lower Urinary Tract Symptoms | 4 |
| Muscle Spasticity | 4 |
| Anxiety Disorders | 3 |
| Ataxia | 2 |
Trials
Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.
49 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.